Synthesis and validation of [18F]mBPET-1, a fluorine-18 labelled mTOR inhibitor derivative based on a benzofuran backbone
Abstract Background Targeted therapy of HER2 positive breast cancer has led to clinical success in some cases with primary and secondary resistance being major obstacles. Due to the substantial involvement of mTOR kinase in cell growth and proliferation pathways it is now targeted in combination tre...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SpringerOpen
2020-01-01
|
| Серии: | EJNMMI Radiopharmacy and Chemistry |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s41181-020-0089-9 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|